Although AMD patients do not have CCL2 and CX3CR1 deficiency, many of them do have other immune-related gene polymorphisms, including genes involved in the complement system [53], TLRs [15], [54], and CX3CR1 [16], [17], [19]. Here, CCL2 is linked to age-related macular degeneration.